Natalia Pérez-Ferre

Dr. Natalia Pérez-Ferre

Medical Doctor, Endocrinologist. PhD. Hospital Clinico San Carlos, Madrid (Spain).
+1
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2014 in Diabetes Care
Verified
Journal Article
Open access
PDF file
ADAlejandra Duran
Alejandra Duran
SSSofía Sáenz
Sofía Sáenz
MTMaría J. Torrejón
María J. Torrejón
EBElena Bordiú
Elena Bordiú
LVLaura del Valle
Laura del Valle
ACAlfonso Calle-Pascual
Alfonso Calle-Pascual
OBJECTIVE The use of the new International Association of the Diabetes and Pregnancy Study Groups criteria (IADPSGC) for the diagnosis of gestational diabetes mellitus (GDM) results in an increased prevalence of GDM. Whether their introduction improves pregnancy outcomes has yet to be established. We sought to evaluate the cost-effectiveness of one-step IADPSGC for screening and diagnosis of GDM compared with traditional two-step Carpenter-Coustan (CC) criteria. RESEARCH DESIGN AND METHODS GDM risk factors and pregnancy and newborn outcomes were prospectively assessed in 1,750 pregnant women from April 2011 to March 2012 using CC and in 1,526 pregnant women from April 2012 to March 2013 using IADPSGC between 24 and 28 weeks of gestation. Both groups received the same treatment and follow-up regimes. RESULTS The use of IADPSGC resulted in an important increase in GDM rate (35.5% vs. 10.6%) and an improvement in pregnancy outcomes, with a decrease in the rate of gestational hypertension (4.1 to 3.5%: −14.6%, P < 0.021), prematurity (6.4 to 5.7%: −10.9%, P < 0.039), cesarean section (25.4 to 19.7%: −23.9%, P < 0.002), small for gestational age (7.7 to 7.1%: −6.5%, P < 0.042), large for gestational age (4.6 to 3.7%: −20%, P < 0.004), Apgar 1-min score <7 (3.8 to 3.5%: −9%, P < 0.015), and admission to neonatal intensive care unit (8.2 to 6.2%: −24.4%, P < 0.001). Estimated cost savings was of €14,358.06 per 100 women evaluated using IADPSGC versus the group diagnosed using CC. CONCLUSIONS The application of the new IADPSGC was associated with a 3.5-fold increase in GDM prevalence in our study population, as well as significant improvements in pregnancy outcomes, and was cost-effective. Our results support their adoption.

1 January 2010 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
Natalia Pérez-FerreNatalia Pérez-Ferre
Natalia Pérez-Ferre
MGMercedes Galindo
Mercedes Galindo
MFM. Dolores Fernández
M. Dolores Fernández
VVVictoria Velasco
Victoria Velasco
IRIsabelle Runkle
Isabelle Runkle
ACAlfonso Calle-Pascual
Alfonso Calle-Pascual
Objective. To evaluate the feasibility of a telemedicine system based on Internet and a short message service in pregnancy and its influence on delivery and neonatal outcomes of women with gestational diabetes mellitus (GDM).Methods. 100 women diagnosed of GDM were randomized into two parallel groups, a control group based on traditional face-to-face outpatient clinic visits and an intervention group, which was provided with a Telemedicine system for the transmission of capillary glucose data and short text messages with weekly professional feedback. 97 women completed the study (48/49, resp.).Main Outcomes Measured. The percentage of women achieving HbA1c values <5.8%, normal vaginal delivery and having a large for-gestational-age newborn were evaluated.Results. Despite a significant reduction in outpatient clinic visits in the experimental group, particularly in insulin-treated women (2.4 versus 4.6 hours per insulin-treated woman resp.;P<.001), no significant differences were found between the experimental and traditional groups regarding HbA1c levels (all women had HbA1c <5.8% during pregnancy), normal vaginal delivery (40.8% versus 54.2%, resp.;P>.05) and large-for-gestational-age newborns (6.1% versus 8.3%, resp.;P>.05).Conclusions. The system significantly reduces the need for outpatient clinic visits and achieves similar pregnancy, delivery, and newborn outcomes.

1 February 2010 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
Natalia Pérez-FerreNatalia Pérez-Ferre
Natalia Pérez-Ferre
MGMercedes Galindo
Mercedes Galindo
MFMª Dolores Fernández
Mª Dolores Fernández
VVVictoria Velasco
Victoria Velasco
MCMª José de la Cruz
Mª José de la Cruz
ACAlfonso L. Calle-Pascual
Alfonso L. Calle-Pascual

1 August 2015 in Clinical Nutrition
Verified
Journal Article
Closed access
Natalia Pérez-FerreNatalia Pérez-Ferre
Natalia Pérez-Ferre
LVLaura Del Valle
Laura Del Valle
MTMaria José Torrejón
Maria José Torrejón
IBIdoya Barca
Idoya Barca
MCMaría Isabel Calvo
María Isabel Calvo
ACAlfonso L. Calle-Pascual
Alfonso L. Calle-Pascual

1 September 2012 in Endocrine Practice
Verified
Journal Article
Closed access
Natalia Pérez-FerreNatalia Pérez-Ferre
Natalia Pérez-Ferre
MTMaria José Torrejon
Maria José Torrejon
MFManuel Enrique Fuentes Ferrer
Manuel Enrique Fuentes Ferrer
MFMaria Dolores Fernandez
Maria Dolores Fernandez
ARAna Ramos
Ana Ramos
ACAlfonso L. Calle-Pascual
Alfonso L. Calle-Pascual

1 January 2012 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
ARAna M. Ramos-Leví
Ana M. Ramos-Leví
Natalia Pérez-FerreNatalia Pérez-Ferre
Natalia Pérez-Ferre
MFM. Dolores Fernández
M. Dolores Fernández
LVLaura del Valle
Laura del Valle
EBElena Bordiu
Elena Bordiu
ACAlfonso Calle-Pascual
Alfonso Calle-Pascual
The aim of this study is to establish a risk appraisal model for GDM by identifying modifiable factors that can help predict the risk of GDM in a large population of 2194 women living in Spain. They were recruited between 2009-2010 when screening for GDM was performed. Participants completed a questionnaire on socio-demographic, anthropomorphic and behavioral characteristics, and reproductive and medical history. A total of 213 (9.7%) women were diagnosed as having GDM. Age, pregestational body weight (BW) and body mass index (BMI), and number of events of medical, obstetric and family history were significantly associated with GDM. After logistic regression model, biscuits and pastries intake <4 times/week, red and processed meats intake <6 servings/week, sugared drinks 30 minutes/day, and 30 minutes/day of sports at least 2 days/week, compared with opposite consumption, was associated with less GDM risk. Our study identified several pregestational modifiable lifestyle risk factors associated with an increase in the risk of developing GDM. This may represent a promising approach for the prevention of GDM and subsequent complications. Further intervention studies are needed to evaluate if this appraisal model of risk calculation can be useful for prevention and treatment of GDM.